The reiteration of a Buy rating and maintenance of a $45 price target by a reputable analyst like Edward White could positively influence investor sentiment towards TG Therapeutics. This endorsement reaffirms the analyst's confidence in the company's prospects, potentially leading to increased investor interest and a positive short-term impact on the stock price.